Abeona Therapeutics Inc Asset Turnover Ratio (ABEO), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abeona Therapeutics Inc   (NASDAQ: ABEO)
 

Abeona Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Abeona Therapeutics Inc asset turnover ratio, the ability of Abeona Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.14 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as ABEO's position remain challenging.

Within sector 145 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2721 to 3221.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABEO Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -20.37 % 99.76 % 106.59 % 93.24 % 84.07 %
Y / Y Revenue Change 697.48 % 669.01 % 581.04 % 40.62 % 19.82 %
Asset Turnover Ratio (TTM) 0.14 0.09 0.06 0.03 0.03
ABEO's Total Ranking # 3221 # 2721 # 2692 # 3449 # 2826
Seq. Asset Change -2.62 % -9.6 % -3.47 % -6.3 % 144.3 %
Seq. Revenue Change 12.96 % 44.6 % 316.69 % 17.17 % 8.93 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 449
Overall Market # 3221

Asset Turnover Ratio Statistics
High Average Low
2.12 0.42 0
(Mar 31 2013)   (Dec 31 2018)




ABEO Company Profile • Back to ABEO Efficiency Comparisons • Compare ABEO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Alpha Teknova Inc   0.43 $ 43.407  Millions$ 101.436  Millions
Collegium Pharmaceutical Inc   0.43 $ 751.744  Millions$ 1,762.977  Millions
Kestra Medical Technologies Ltd   0.42 $ 105.939  Millions$ 249.617  Millions
Picard Medical Inc   0.42 $ 5.983  Millions$ 14.114  Millions
Bausch Health Companies Inc   0.42 $ 10,853.000  Millions$ 25,620.500  Millions
Lemaitre Vascular Inc   0.42 $ 262.923  Millions$ 620.959  Millions
Xilio Therapeutics Inc   0.42 $ 64.092  Millions$ 151.530  Millions
Dyadic International Inc   0.42 $ 3.802  Millions$ 8.991  Millions
Surgery Partners Inc   0.42 $ 3,366.300  Millions$ 8,039.525  Millions
Amgen Inc   0.41 $ 38,095.000  Millions$ 92,217.500  Millions
Regenxbio Inc   0.41 $ 174.482  Millions$ 426.687  Millions
Verastem Inc   0.41 $ 87.526  Millions$ 214.403  Millions
Medtronic Plc  0.41 $ 37,542.000  Millions$ 92,340.000  Millions
Viatris Inc   0.40 $ 14,737.300  Millions$ 36,748.175  Millions
Jazz Pharmaceuticals Plc  0.40 $ 4,601.233  Millions$ 11,489.081  Millions
Rxsight Inc   0.40 $ 127.729  Millions$ 319.260  Millions
Zai Lab Limited  0.40 $ 449.614  Millions$ 1,125.463  Millions
Immunocore Holdings Plc  0.40 $ 430.775  Millions$ 1,090.322  Millions
Quanterix Corporation  0.39 $ 152.716  Millions$ 387.301  Millions
Becton Dickinson And Company  0.39 $ 20,840.000  Millions$ 53,053.250  Millions
Schrodinger Inc   0.39 $ 259.035  Millions$ 663.600  Millions
Butterfly Network Inc   0.39 $ 112.360  Millions$ 288.863  Millions
Bausch and Lomb Corp  0.38 $ 5,324.000  Millions$ 13,873.250  Millions
Biomarin Pharmaceutical Inc  0.38 $ 3,406.614  Millions$ 8,880.837  Millions
Aligos Therapeutics Inc   0.38 $ 31.518  Millions$ 82.296  Millions
Veracyte Inc   0.38 $ 544.735  Millions$ 1,424.143  Millions
Protagonist Therapeutics inc   0.38 $ 281.992  Millions$ 738.220  Millions
Beta Bionics Inc   0.38 $ 119.513  Millions$ 313.898  Millions
Regeneron Pharmaceuticals Inc   0.38 $ 15,534.700  Millions$ 40,831.875  Millions
Novavax inc   0.38 $ 413.796  Millions$ 1,088.785  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.